A 28-year-old woman with a 1-year history of progressive unilateral hearing loss is found to have otosclerosis on audiometry and CT. She is currently asymptomatic with a 35 dB air-bone gap in the affected ear. She is anxious about surgery and requests a trial of medical management first. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has: - **Unilateral otosclerosis** with moderate conductive hearing loss (35 dB air-bone gap) - **Early-stage disease** (1 year duration, asymptomatic) - **Patient preference** for non-surgical management initially - **Functional hearing** preserved in the affected ear ## Management Strategy for Early/Mild Otosclerosis ### Observation and Hearing Aids **Key Point:** In patients with mild-to-moderate conductive hearing loss from otosclerosis who are reluctant to undergo surgery, a **trial of hearing aids with regular audiometric monitoring** is a reasonable initial approach. **High-Yield:** The decision to operate should be based on: 1. **Degree of hearing loss** (air-bone gap >40 dB favors surgery) 2. **Patient symptoms and functional impact** 3. **Patient preference and fitness for surgery** 4. **Rate of progression** (rapid progression may warrant earlier intervention) ### Why Hearing Aid Trial? - Hearing aids are non-invasive and reversible. - They allow the patient to experience functional benefit before committing to surgery. - Many patients with otosclerosis benefit significantly from amplification. - If the patient later requests surgery, the option remains available. - Regular audiometry (every 6–12 months) tracks progression and helps guide future surgical timing. **Clinical Pearl:** Patients with a 35 dB air-bone gap often function reasonably well with hearing aids. Surgery becomes more compelling when the gap exceeds 40–50 dB or when the patient is significantly symptomatic despite aids. ### Why NOT the Other Options? | Option | Why Incorrect | |--------|---------------| | Sodium fluoride | No robust evidence supports fluoride in halting otosclerosis. It is not standard first-line therapy. Hearing aids + observation is preferred for mild disease. | | Immediate stapedectomy | The patient is asymptomatic with mild-to-moderate loss and explicitly requests non-surgical management. Surgery is not indicated at this stage; it can be offered later if hearing deteriorates or the patient changes her mind. | | Genetic counseling alone | While genetic counseling may be appropriate (otosclerosis has autosomal dominant inheritance with incomplete penetrance), deferring all intervention without offering hearing aids leaves the patient without functional support. | ## Audiometric Monitoring Protocol **Mnemonic: SAM** — Serial Audiometry Monitoring - **S**erial: Every 6–12 months - **A**ir-bone gap tracking - **M**anagement adjustment based on progression If audiometry shows: - Rapid progression (>5 dB/year air-bone gap increase) → consider earlier surgery - Stable or slow progression → continue hearing aids and observation - Patient becomes symptomatic despite aids → offer surgery [cite:Dhingra 8e Ch 10; Cummings Otolaryngology 7e Ch 136]